Not available
Quote | Syneos Health Inc. (NASDAQ:SYNH)
Last: | $42.98 |
---|---|
Change Percent: | 0.0% |
Open: | $42.98 |
Close: | $42.98 |
High: | $42.99 |
Low: | $42.97 |
Volume: | 7,386,241 |
Last Trade Date Time: | 09/27/2023 03:00:00 am |
News | Syneos Health Inc. (NASDAQ:SYNH)
Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S. PR Newswire JERSEY CITY, N.J. , April 29, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) is celebrating its eight-year anniversary of being established in th...
Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting PR Newswire Presentations span Parkinson's disease and ALS clinical and real-world evidence Oral platform sessions will highlight r...
Message Board Posts | Syneos Health Inc. (NASDAQ:SYNH)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $SYNH News Article - Syneos Health Extends Partnership with Medable | whytestocks | investorshangout | 12/13/2022 4:35:52 PM |
whytestocks: $SYNH News Article - Syneos Health Reports First Quarter 2022 Results | whytestocks | investorshangout | 04/29/2022 3:10:49 PM |
whytestocks: $SYNH News Article - Syneos Health, inc (SYNH) Q3 2021 Earnings Call Transcript | whytestocks | investorshangout | 11/03/2021 8:55:50 PM |
whytestocks: $SYNH News Article - Syneos Health Reports Third Quarter 2021 Results | whytestocks | investorshangout | 11/03/2021 8:50:49 PM |
whytestocks: $SYNH News Article - Syneos Health Reports Second Quarter 2019 Results | whytestocks | investorshangout | 08/06/2019 2:45:38 PM |
News, Short Squeeze, Breakout and More Instantly...
Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S. PR Newswire JERSEY CITY, N.J. , April 29, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) is celebrating its eight-year anniversary of being established in th...
Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting PR Newswire Presentations span Parkinson's disease and ALS clinical and real-world evidence Oral platform sessions will highlight r...
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) PR Newswire Orphan Drug Exclusivity recognized for RADICAVA ORS based on major contribution to patient care JERSEY CITY, N.J. ...